Events & Publications
|Excellent performance, respected globally.|
Being an international player in the Female health care segment, Famy Care has been constantly in the news for its new strategic tie-ups, alliances, new product launches and approvals.
Famy Care has participated in various health care forums, seminars and conferences on a global level, which are focussed on women’s reproductive health care.
Being the first WHO pre-qualified manufacturer of generic contraceptives, Famy Care has created a global footprint with quality products and expertise in reproductive health domain.
|Mylan Announces Famy Care Received Final FDA Approval for ANDA for Levonorgestrel, Ethinyl Estradiol Tablets
Acquire Media, December 28, 2012
|AIF Capital to invest $40 mn in Famy Care
AIF Capital, April 15, 2010